相关实验视频
Updated: Jul 11, 2025

Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
在炎症性肠病中患淋巴瘤的风险
1Dr. Siegel serves as Director of the Inflammatory Bowel Disease Center in the Section of Gastroenterology and Hepatology at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.
患有炎症性肠病的患者面临着对淋巴瘤风险的焦虑. 虽然像免疫调节剂这样的治疗方法可能会略微增加这种风险,但它们的好处远远超过了小的潜在危害.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 炎症性肠病 (IBD) 患者对淋巴瘤风险感到严重焦虑.
- 对免疫调节剂和抗瘤亡因子剂的担忧可能会增加淋巴瘤风险,这可能会影响治疗决策和治疗坚持.
- 关于绝对风险的不确定性使患者和提供者之间的讨论变得复杂.
研究的目的:
- 审查有关炎症性肠病患者淋巴瘤风险的当前数据.
- 评估炎症性肠病本身与淋巴瘤发展之间的关联.
- 评估与用于IBD的免疫抑制疗法相关的淋巴瘤风险.
主要方法:
- 对调查IBD淋巴瘤风险的研究进行文献综述.
- 对IBD,免疫抑制治疗和淋巴瘤发病率的数据分析.
- 综合信息,以提供一个平衡的风险-收益的观点.
主要成果:
- 与炎症性肠病治疗相关的淋巴瘤风险增加是公认的.
- 治疗IBD的实质性益处通常超过了非常小的淋巴瘤风险.
- 目前的数据旨在澄清绝对风险,以改善患者与医疗服务提供者之间的沟通.
结论:
- 炎症性肠病治疗提供了重要的好处,这些好处对于管理这种疾病至关重要.
- 虽然淋巴瘤风险略有增加,但与治疗益处相比,它被认为非常小.
- 有信息的决策需要了解IBD疗法的细微风险-益处概况.
相关概念视频
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

